The FDA allows emergency use in response to positive trials, but more research is needed.
The FDA allows emergency use in response to positive trials, but more research is needed.
The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.
A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.
A new study builds upon earlier research with a larger, more up-to-date dataset, finding a reversal in trends.
Though they’re only needed for special cases in workers’ comp, anticancer medications can easily exceed $10,000 per monthly fill.
Can special implants in the brain override paralysis? The FDA believes one day they could.
Prescribing has doubled since 2003, overdose deaths quadrupled since 1996, and misuse accounts for 20% of benzodiazepine use.
A new JAMA study finds that increased county-level opioid marketing was tied to elevated overdose mortality.
An analysis of 90,000 private claims explores the relationship between early PT and reduced long-term opioid use in musculoskeletal pain.
A study of 9,596 claimants who filled an opioid prescription found that 30% were still taking opioids 90 days later.
